Public Reference

Industry Primers

Bottom-up NAICS industry primers written for both public-market and private investors. Leaf industries are researched from the ground up; every group, subsector, and sector above them reads as a contrast across the industries beneath it.

2122 industries · 24 sectors · NAICS 2022

Researched with AI assistance from official U.S. statistics and independent sources, with citations on every page. Figures are not individually verified against pinned evidence — primers marked Evidence-verified are. Industry research, not investment advice. Methodology.

IndustryNAICS 54172Professional, Scientific, and Technical Services

Research and Development in the Social Sciences and Humanities (NAICS 54172)

A Histometrics industry-group primer for public- and private-market investors

Read this first — this is a pass-through level. NAICS 54172 is a five-digit industry group that contains exactly one six-digit industry: 541720, Research and Development in the Social Sciences and Humanities. Because there is only one child, this group is effectively identical to that child — the codes cover the same firms, the same revenue, and the same statistics. This page gives the group-level numbers and the shape of the business; for the full treatment — the investable universe, contract mechanics, demand drivers, regulation, and risks — see the 541720 primer.

1. Overview

This industry group is the business of producing knowledge about people, institutions, and culture — economics, sociology, psychology, political science, education, public-health behavior, linguistics, and history. Its output is not a product but evidence: program evaluations, survey datasets, policy analyses, cost-benefit studies, behavioral research, and expert testimony, sold under contracts and grants [1].

For an investor the key facts are simple. It is a labor-and-knowledge services business — firms make money by hiring credentialed researchers (often PhDs) and keeping them billable on funded projects, the same economics as engineering or management consulting. Demand is unusually policy-driven: the single largest buyer is the U.S. federal government, which makes the group steady in normal times but sharply exposed to shifts in the federal budget — an exposure that turned into an outright shock in 2025 (see 541720, Sections 6, 9, 10).

2. What's inside — and why the group equals its one child

NAICS uses a nested numbering system: the five-digit group 54172 breaks down into six-digit industries. Here there is only one.

Six-digit child Name Share of the group
541720 Research and Development in the Social Sciences and Humanities 100%

With a single child, the group is a pass-through: every dollar of receipts, every firm, and every employee counted at 54172 is the same dollar, firm, and employee counted at 541720. There is no aggregation to do and no sibling industries to weigh against each other. The distinction between the two codes is purely a level in the classification hierarchy, not a difference in what is being measured.

3. How big it is

Our ground-truth federal figures for NAICS 54172. County Business Patterns (CBP) data are for 2023; Economic Census receipts and concentration data are for 2022 — so these are not a single-year income statement. They match the 541720 figures exactly, as the pass-through implies.

Metric Value Source
Receipts (2022) $9.30 billion 2022 Economic Census [2]
Firms (2022) 1,782 2022 Economic Census [2]
Employer establishments (2023) 2,082 County Business Patterns [3]
Paid employees (2023) 46,634 County Business Patterns [3]
Annual payroll (2023) $4.28 billion County Business Patterns [3]
First-quarter payroll (2023) $1.06 billion County Business Patterns [3]
Avg. annual pay (derived) ~$91,800 payroll ÷ employees [3]

An establishment is a physical operating location; a firm may own several. Average receipts per firm are roughly $5.2 million ($9.30B ÷ 1,782) and the average establishment holds about 22 employees (46,634 ÷ 2,082) — but those averages hide a bimodal structure: a dozen-plus large multi-program institutes plus a long tail of small and solo research shops (Section 8). The federal file provides no group-wide figures for operating margins, utilization, backlog, or client concentration, so we do not state them.

The undercount caveat is large here. The $9.30 billion receipts figure counts only for-profit and nonprofit business establishments classified in 54172. It systematically misses the three biggest venues for this research: (a) universities, where most federally funded behavioral and social research is actually performed (classified under education, NAICS 611310, not here); (b) government agencies doing research in-house (Census, the Bureau of Labor Statistics, the USDA Economic Research Service), which CBP excludes; and (c) the smallest operators — independent scholars and nonemployer businesses captured only in separate Nonemployer Statistics [3]. The true footprint of U.S. social-science and humanities research is several times this business-statistics number; see the 541720 primer for the federal-obligations comparison.

4. Where the value concentrates

Because the group is its one child, the investable map is identical to 541720's — summarized here, detailed there.

  • No pure-play public company is dedicated solely to social-science and humanities research. Listed exposure is indirect, through diversified government-and-commercial consultancies where such work is one line among many: ICF International (NASDAQ: ICFI, ~$2.0B revenue) for social-program evaluation and survey work, and Charles River Associates (NASDAQ: CRAI, $687M revenue) for antitrust, damages, and regulatory economics [4][5]. Booz Allen Hamilton (NYSE: BAH), Maximus (NYSE: MMS), Ipsos, and YouGov offer more distant, mostly-adjacent exposure.
  • The real center of gravity is nonprofit or closely held and not directly investable as equity: RAND, NORC, Westat, Mathematica, Abt Global, the American Institutes for Research, RTI International, and think tanks such as the Urban Institute and Brookings. Nine of these policy-research leaders alone employ more than 20,000 people [6] — roughly half the entire measured group's workforce, underscoring the classification/undercount issue in Section 3.

5. How the money works

Revenue is almost entirely project-based — won as contracts and grants from federal agencies, state and local governments, foundations, universities, and corporate research budgets, not sold off a shelf. The core mechanic is billing direct labor and recovering overhead: a researcher's hours bill directly to a project, and the firm layers on negotiated indirect cost rates (for nonprofits, a facilities-and-administrative, or F&A, rate) to recover expenses not tied to one project. The levers owners watch are billable utilization (idle PhDs are how this business loses money), indirect-rate competitiveness, backlog and book-to-bill, and win/renewal rates. Margins split by mix: the pure-government, cost-reimbursement end is low-margin, steady, and relationship-driven (ICF runs ~11% adjusted-EBITDA margin), while the commercial/litigation-economics end is higher-margin and cyclical with the economy rather than the federal budget [4][5]. Full mechanics are in 541720, Section 5.

6. What drives demand

Demand tracks who buys evidence and how much they will pay. The dominant buyer is the federal government — the National Science Foundation's Social, Behavioral and Economic Sciences directorate, the Institute of Education Sciences, the National Institutes of Health's behavioral research, and the National Endowment for the Humanities — reinforced by evidence-based-policy mandates (the Foundations for Evidence-Based Policymaking Act). State and local governments, private foundations, international donors, and commercial/litigation economics (antitrust and damages work, the resilient counter-cyclical slice) round out the mix. Because government dominates, aggregate demand is politically cyclical. Looking forward, artificial intelligence (AI) will automate routine literature reviews and reporting while raising the premium on what it cannot fake — credible samples, causal inference, and defensible methods. Detail in 541720, Section 6.

7. Regulation

There is no product regulator. The binding rules govern contracting, research ethics, and data: the Federal Acquisition Regulation (FAR) Part 31 and OMB Uniform Guidance (2 CFR 200) on allowable and indirect costs; the Common Rule (45 CFR 46) requiring Institutional Review Board (IRB) review and informed consent for human-subjects research; and data-privacy law — FERPA (education records), HIPAA (health data), and CIPSEA (federal statistical confidentiality) — plus Paperwork Reduction Act clearance for federal surveys. These are both a barrier to entry and a live source of policy risk, most acutely the fight to cap indirect-cost recovery (see 541720, Sections 7 and 9).

8. Consolidation

By our federal concentration data this is a fragmented, unconcentrated market [2]:

Concentration (2022) Value
Top 4 firms' revenue share (CR4) 30%
Top 8 (CR8) 43%
Top 20 (CR20) 57.8%
Top 50 (CR50) 73%
Herfindahl-Hirschman Index (HHI) 390.2

An HHI of 390 sits far below the 1,500 threshold antitrust agencies treat as "unconcentrated," and a CR4 of just 30% confirms it. The structure is bimodal — a dozen-plus large institutes over a long tail of small specialists and solo shops, many under the SBA's $28 million small-business receipts threshold and eligible for contract set-asides. Consolidation is real but gradual (private-equity roll-ups of government-services firms, rebrandings, university spin-outs), and the tax-exempt segment structurally limits classic M&A because nonprofit institutes cannot simply be bought. Detail in 541720, Section 8.

9. Risks

The risk profile is 541720's, unchanged by the roll-up:

  • Federal budget and political cyclicality — acute now. In 2025, government-efficiency contract reviews terminated large volumes of research work (Mathematica and AIR each lost 15 Institute of Education Sciences agreements), the National Endowment for the Humanities cancelled more than 1,200 grants, and the NSF social-science directorate faced a fiscal-2026 request slashing it to roughly a third of its prior level — an unresolved appropriations fight.
  • Indirect-rate cap risk. A 2025 attempt to cap NIH indirect (F&A) reimbursement at 15%, versus negotiated rates averaging ~58%, was blocked in court but signals durable pressure to compress overhead recovery — a direct hit to the economics in Section 5.
  • Buyer concentration on the federal government amplifies every budget swing.
  • Reputational/methodological risk — credibility is the product; a contested or non-reproducible study can cost re-competes.
  • AI-driven commoditization, talent scarcity, data-access, and cybersecurity risks round out the list.

Full discussion in 541720, Section 9.

10. How to invest and outlook

Because 54172 is its one child, the routes are identical to 541720's.

  • Public-market: no pure play. Practical listed exposure is ICF International (ICFI) for government program evaluation and survey work and Charles River Associates (CRAI) for litigation and regulatory economics [4][5] — both thematic, not pure, because most of their revenue sits outside this code; adjust for the unrelated businesses before comparing multiples. CRAI's commercial mix makes it the more insulated of the two from the 2025 federal-budget shock.
  • Private-market: the heart of the field — RAND, NORC, Westat, Mathematica, Abt, AIR, the Urban Institute — is nonprofit or employee-owned and not directly investable as equity; reach it through contracts, partnership, or private credit, or gain equity exposure indirectly via PE-backed government-services platforms that acquire evaluation and analytics capabilities.
  • Near-term outlook: the dominant variable is the trajectory of federal research funding and the unresolved NSF appropriations split between House and Senate. Expect federal social-program-evaluation work to stay under pressure through the current budget cycle, while commercial/litigation economics and state, local, and foundation-funded work look more resilient. The structural demand for evidence remains intact; the swing factor is how much of it Washington chooses to fund in any given year.

For the complete primer — full investable-universe tables, contract-type economics, demand-driver detail, the regulatory map, consolidation dynamics, and the full risk register — see NAICS 541720.


Sources

Drawn from the 541720 child primer; consult it for the complete numbered source list.

  1. U.S. Census Bureau, 2022 NAICS Manual — definition and scope of "541720 – Research and Development in the Social Sciences and Humanities," including adjacent-code exclusions. https://www.census.gov/naics/reference_files_tools/2022_NAICS_Manual.pdf
  2. U.S. Census Bureau, 2022 Economic Census — Concentration of Largest Firms — receipts, firm counts, and concentration ratios (CR4/CR8/CR20/CR50, HHI) for NAICS 54172/541720. https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN
  3. U.S. Census Bureau, County Business Patterns (CBP), 2023 (establishments, employment, payroll) and Nonemployer Statistics / CBP methodology (employer-establishment coverage; exclusion of government and nonemployer businesses). https://www.census.gov/data/datasets/2023/econ/cbp/2023-cbp.html
  4. ICF International, "ICF Reports Fourth Quarter and Full Year 2024 Results," Feb. 27, 2025 (FY2024 revenue ~$2.0B; adjusted-EBITDA margin ~11%; book-to-bill 1.24). https://icf.mediaroom.com/2025-02-27-ICF-Reports-Fourth-Quarter-and-Full-Year-2024-Results
  5. Charles River Associates, "CRA Reports Fourth-Quarter and Full-Year 2024 Financial Results," Feb. 20, 2025 (FY2024 revenue $687.4M; FY2025 guide $715–735M). https://www.businesswire.com/news/home/20250220132389/en/Charles-River-Associates-CRA-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results
  6. Urban Institute, "Introducing the Evidence and Equity Collaborative," 2025 (nine policy-research leaders; >20,000 employees). https://www.urban.org/press-releases/introducing-evidence-and-equity-collaborative